WELL Health Technologies (TSE:WELL) Price Target Raised to C$8.00 – MarketBeat
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
WELL Health Technologies (TSE:WELL – Get Rating) had its target price upped by TD Securities from C$7.00 to C$8.00 in a research note issued on Friday, BayStreet.CA reports. The brokerage currently has a “buy” rating on the stock. TD Securities’ price target would suggest a potential upside of 96.56% from the stock’s current price.
WELL has been the topic of a number of other research reports. Canaccord Genuity Group lowered their price target on shares of WELL Health Technologies from C$10.00 to C$6.00 in a report on Friday, May 20th. CIBC lowered their price target on shares of WELL Health Technologies from C$8.00 to C$6.50 and set an “outperform” rating on the stock in a report on Friday, May 20th. Scotiabank lowered their price target on shares of WELL Health Technologies from C$9.00 to C$7.50 in a report on Friday, May 20th. Finally, Haywood Securities reaffirmed a “buy” rating and issued a C$12.00 price target on shares of WELL Health Technologies in a report on Monday, April 25th. Six investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus price target of C$9.25.
WELL Health Technologies Stock Up 4.4 %
TSE WELL traded up C$0.17 during trading hours on Friday, hitting C$4.07. The company’s stock had a trading volume of 940,241 shares, compared to its average volume of 990,892. WELL Health Technologies has a 52 week low of C$2.98 and a 52 week high of C$8.25. The company has a market capitalization of C$904.42 million and a PE ratio of -18.49. The company has a current ratio of 0.81, a quick ratio of 0.74 and a debt-to-equity ratio of 53.17. The company’s 50-day simple moving average is C$3.37 and its two-hundred day simple moving average is C$4.06.
About WELL Health Technologies
(Get Rating)
WELL Health Technologies Corp. operates as a practitioner focused digital health company in Canada, the United States, and internationally. It offers end-to-end omni-channel patient services, including primary care; physiotherapy, occupational therapy, chiropractic, dietary, mental health counselling, and sleep related services; specialized care, including gastroenterologists; diagnostic services related to cardiology, women's health, and bone/muscle health and cancer diagnostics; and telehealth services.
Featured Articles
- What Is WallStreetBets and What Stocks Are They Targeting?
- Institutions And Analysts Propel Jack In The Box Higher
- Can You Guess Which EV Stock Is Beating Tesla ?
- Look at Honeywell for a Steady and Diversified Stock
- Why Invest in High-Yield Dividend Stocks?
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider WELL Health Technologies, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and WELL Health Technologies wasn’t on the list.
While WELL Health Technologies currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Complete the form below to receive the latest headlines and analysts’ recommendations for your stocks with our free daily email newsletter:
What investors can learn from studying the past, as well as offering some ideas about asset classes with future potential.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.
Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.
Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.
As Featured By:
MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.
Twitter Facebook StockTwits Financial Juice YouTube
© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.
Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds
© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart’s disclaimer.